ACOR News & Analysis
Cramer Interviews Acorda Therapeutics CEO
19 Jun 2012 EDT -
On Tuesday, Acorda Therapeutics CEO Ron Cohen appeared on “Mad Money” to offer insight on his company’s multiple sclerosis drug "AMPYRA.”
To Cramer, the drug could be a huge driver for the stock . But he wanted to get the perspective of the company’s CEO, so he was happy to chat with Cohen. Watch the video to see the full interview.
Call Cramer: 1-800-743-CNBC
Questions for Cramer? madmoney@cnbc.com
Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com
ACOR News & Analysis
© 2012 CNBC.com All Rights Reserved
DATA IS REAL-TIME EXCEPT NOTED WITH *
* DATA DELAYED AT LEAST 15 MINUTES
DATA IS REAL-TIME EXCEPT NOTED WITH *
* DATA DELAYED AT LEAST 15 MINUTES